Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed125%
recruiting250%
terminated125%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers

NCT04699305
recruitingnot_applicable

Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence

NCT04899466
terminatednot_applicable

Post Marketing Trial for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard To Heal Wounds

NCT04745806
completednot_applicable

Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs

NCT04185558

Clinical Trials (4)

Showing 4 of 4 trials
NCT04699305

Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers

Recruiting
NCT04899466Not Applicable

Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence

Recruiting
NCT04745806Not Applicable

Post Marketing Trial for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard To Heal Wounds

Terminated
NCT04185558Not Applicable

Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4